Presence & RecognitionEvent: August 31, 2026
Morphocell Technologies employee Drs. Massimiliano Paganelli and Claudia Raggi were selected by BIOTECanada as 2026 Gold Lead Award recipients for the Community Leadership Award (Research & Innovation).
Published
Signal category
Presence & Recognition
Quote
“BIOTECanada as 2026 Gold Lead Award recipients for the Community Leadership Award (Research & Innovation)”
— Stephen Shapka|Morphocell Technologies team
Company
Morphocell Technologies
Transforming the treatment of liver disease
- Industry
- Biotechnology Research
- Location
- Laval, CA
- Company size
- 49 employees
Morphocell Technologies Inc. is a regenerative medicine company focused on the development and commercialization of stem cell therapies and engineered tissue implants that target liver failure. The Company is supported by Series A investment to achieve Phase 1 clinical trials. Morphocell Technologies aims at bringing to market the first effective treatment for acute, chronic and acute-on-chronic liver failure.
Founded 2018